Scripps 36th Annual New Treatments in Chronic Liver Disease 2022 (CME VIDEOS)

Overview

Scripps 36th Annual New Treatments in Chronic Liver Disease 2022 (CME VIDEOS) presents the latest advancements in medications and therapies for liver disease and transplantation. This conference review covers oral drug treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease (NAFLD), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), hepatocellular carcinoma (HCC), and complications of end-stage liver disease including thrombocytopenia. The program offers a comprehensive yet concise update for physicians managing common and complex liver conditions.

On-demand gastroenterology education — accessible anytime, anywhere.

Agenda

This comprehensive conference program addresses clinical guidelines, emerging therapies, and management strategies in chronic liver disease.

• ACG Guidelines for DILI and Hemochromatosis — Kris Kowdley, MD
• Acute-on-Chronic Liver Disease — Timothy Morgan, MD
• Advanced Endoscopy in Liver Disease Patients — Matthew Skinner, MD
• Advances in HCC — Catherine Frenette, MD
• AGA Guidelines for NAFLD — Mazen Noureddin, MD
• Autoimmune Hepatitis — John Vierling, MD
• Debate: Use of Semaglutide for Obese Patients with NAFLD — Paul J. Pockros, MD, Michael Charlton, MD
• EASL Guidelines for Non-Invasive Testing — Michael Charlton, MD
• Panel Discussion 1
• Panel Discussion 2
• Panel Discussion 3
• Reproductive Health and Chronic Liver Disease — Norah Terrault, MD
• Update on Management of Ascites and Hepatorenal Syndrome — Florence Wong, MD
• Vascular Disorders and Anticoagulation — Patrick Northup, MD
• Viral Hepatitis B and C — Julio Gutierrez, MD
• When to Refer for Liver Transplantation — Adam Deising, MD
• William S. Haubrich Lecture: What’s New in PBC and PSC — Kris Kowdley, MD

Educational Objectives

• Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis, reproductive health, and chronic liver disease.
• Review vascular disorders and coagulation management principles for patients with chronic liver disease.
• Summarize guidelines on NAFLD (AGA), drug-induced liver injury (DILI), hemochromatosis (ACG), and non-invasive fibrosis markers (EASL).
• Evaluate drugs in development for PBC and PSC.
• Employ strategies for treating and managing ascites and hepatorenal syndrome.
• Describe advances in HCC therapy and management of acute-on-chronic liver disease.

Speakers

• Kris Kowdley, MD
• Timothy Morgan, MD
• Matthew Skinner, MD
• Catherine Frenette, MD
• Mazen Noureddin, MD
• John Vierling, MD
• Paul J. Pockros, MD
• Michael Charlton, MD
• Norah Terrault, MD
• Florence Wong, MD
• Patrick Northup, MD
• Julio Gutierrez, MD
• Adam Deising, MD

This conference is organized and presented by Scripps Health and reflects expert insights from leading hepatology specialists. The content is aligned with continuing medical education objectives for ongoing professional development.

Target Audience

• Hepatologists
• Gastroenterologists
• Infectious Disease Specialists

Why This Topic Matters

Scripps 36th Annual New Treatments in Chronic Liver Disease 2022 (CME VIDEOS) provides essential updates in the clinical management of chronic liver diseases, a critical area within gastroenterology. This conference supports physicians’ ability to interpret emerging guidelines and apply new therapeutic options to their clinical practice.

Hosted on MedHub Central, this program reinforces expertise in hepatology and related disciplines by delivering relevant, evidence-based content that informs patient care decisions in chronic liver disease management.